Transfected human B cells: a new model to study the functional and immunostimulatory consequences of APP production.
The ubiquitously expressed Alzheimer amyloid precursor protein (APP) has raised wide interest in view of its connection with Alzheimer's disease. We now provide a novel extraneuronal cell model in which human Epstein-Barr virus transformed B cells that constitutively hardly produce APP are transfected with wild-type or mutated APP695, harboring the Swedish mutation APPsw, or a dilysine endoplasmic reticulum retrieval motif--APP(ER). This leads to the generation of three types of cells, one with a high secretion of soluble APPs but low levels of intracellular APP, another with a high intracellular APP retention but a low APP secretion, and a third in which APP maturation and secretion are strongly impaired. The suitability of our cell model for various purposes is proven by its usage in different systems. We demonstrate that it is a useful tool for studies on the physiology of APPs and represents a good model system to analyze the cellular mechanisms of Abeta-directed autoimmune reactivity.
Marx
F
F
Institute for Biomedical Aging Research of the Austrian Academy of Sciences, Innsbruck.
Blasko
I
I
Zisterer
K
K
Grubeck-Loebenstein
B
B
D016564:Amyloid beta-Protein Precursor / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D017209:Apoptosis; D001324:Autoantigens / Q000276:immunology; D001402:B-Lymphocytes / Q000166:cytology / Q000378:metabolism*; D002455:Cell Division; D002461:Cell Line, Transformed; D006801:Humans; D008954:Models, Biological; D013601:T-Lymphocytes / Q000276:immunology; D014162:Transfection
D016564:Amyloid beta-Protein Precursor; D001324:Autoantigens